Cleared Traditional

K140740 - TRANSONIC TISSUE PERFUSION MONITOR

K140740 is an FDA 510(k) clearance for TRANSONIC TISSUE PERFUSION MONITOR, manufactured by Transonic Systems, Inc.. The device is a Class 2 Cardiovascular device with product code DPW cleared through the Traditional 510(k) pathway after a 485-day FDA review.

K140740 · Transonic Systems, Inc. · Cardiovascular device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Jul 2015
Decision
485d
Days
Class 2
Risk

K140740 is an FDA 510(k) clearance for the TRANSONIC TISSUE PERFUSION MONITOR. Classified as Flowmeter, Blood, Cardiovascular (product code DPW), Class II - Special Controls.

Submitted by Transonic Systems, Inc. (Ithaca, US). The FDA issued a Cleared decision on July 23, 2015 after a review of 485 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2100 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

FDA 510(k) Submission Details - K140740

510(k) Number K140740 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 25, 2014
Decision Date July 23, 2015
Days to Decision 485 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
360d slower than avg
Panel avg: 125d · This submission: 485d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DPW Device Classification - Class 2, Special Controls

Product Code DPW Flowmeter, Blood, Cardiovascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DPW Flowmeter, Blood, Cardiovascular

All 100
Devices cleared under the same product code (DPW) and FDA review panel - the closest regulatory comparables to K140740.
PeriFlux6000
K152930 · Perimed AB · May 2016
CerOX
K150268 · Or-Nim Medical , Ltd. · Nov 2015
Deltex Medical CardioQ-EDM, Deltex Medical CardioQ-EDM+
K150347 · Deltex Medical Limited · Jul 2015
DELTEX MEDICAL CARDIOQ-EDM+
K132139 · Deltex Medical Limited · Oct 2013
CEROX
K131854 · Or-Nim Medical , Ltd. · Sep 2013
SONOTT FLOWLAB(R)
K111730 · Em-Tec GmbH · Jan 2012
K140740 · TRANSONIC TISSUE PERFUSION MONITOR
Download PDF FDA Summary Transonic Systems, In…